India MCA Corporate Compliance Enforcement — March 27, 2026
The 11 filings reveal a surge in SEBI LODR non-compliances, particularly Regulation 17(1) board composition issues, with fines totaling ~₹2.22 Cr across companies like IRFC (₹9.77L), Halder Venture (₹5.43L), SecureKloud (₹3.5 Cr), Panacea Biotec (₹9.38 Cr upheld), and others, signaling widespread governance lapses in Q3/Q4 FY26. Promoter encumbrance spiked in Camlin Fine Sciences to 74% of holding (7.62% total capital) via new pledges totaling 13.25L shares, indicating liquidity stress. Four companies (NGL Fine-Chem, Rodium Realty, Shirpur Gold, implicitly others) closed trading windows from April 1, 2026, ahead of Q4/YE March 2026 earnings, building a catalyst calendar for early April. No explicit YoY/QoQ financial trends or revenue/margin data disclosed, but repeated fines (no waivers granted yet) and ID cessations at MRPL highlight board instability risks, especially in PSUs/infra (IRFC, MRPL). Aditya Birla Money and Unknown Co faced minor penalties (₹2.14L, ₹5.9k). Overall, negative sentiment dominates (7/11 filings), with materiality peaking at 8/10 for Camlin/SecureKloud, implying portfolio-level governance risks in finance/chem/oil sectors and potential stock volatility pre-earnings.